Veirano Advogados advised CV Idexo Fundo de Investimento em Participações Multiestratégia Investimento no Exterior on series seed investment in Intera Talent Hacking Recrutamento, a Brazilian company specialized in recruiting technology, product and data
Tags :Veirano
Veirano Advogados advised Itaú Unibanco on acquisition of an initial stake of 35% in Avenue Holding Cayman, the holding entity of Avenue Securities, a digital investment platform, and Avenue’s corporate control within 2 years. The transaction
Veirano Advogados advised Hospital Care group and the underwriters BTG Pactual and Itaú BBA in the offering. Hospital Vera Cruz S.A., controlled company of Hospital Care Caledonia, executed, through the securitization company True Securitizadora,
Veirano Advogados, and i2a Advogados advised Brookfield Properties through the real estate investment fund PDC II Fundo de Investimento Imobiliário, managed by Banco Genial (Brazil) on the acquisition of 19 floors of the real
With a focus on energy and regulatory matters, lawyer Mariella Gondim Rocha (pictured) is the new partner of Veirano Advogados. Mariella will join the Firm’s broad infrastructure group, directing her practice to the power
Veirano Advogados assisted Valid Soluções in the 9th issue of simple debentures, non convertible into shares, in two series, of unsecured species, to be converted into the species with real guarantee, for public distribution
The deal was Public offering of the 1st issuance of commercial papers of C.A.W. Projetos e Consultoria Industrial. The total value was R$ 60 million. This is the first commercial papers issuance of C.
Veirano Advogados acted as deal counsel for issuer and underwriters on the public offering of the 1st issuance of debentures of Cibrafértil Companhia Brasileira de Fertilizantes. Banco Votorantim was lead coordinator, together with Banco
PPU Peru has advised Terna SpA on the sale of its electricity concessionaires in Peru to Caisse de Dépôt et Placement du Québec
Veirano Advogados advised Dimed Distribuidora de Medicamentos (Grupo Panvel) in debentures issue
